Trials / Completed
CompletedNCT01521481
Ultrasound-guided Inguinal Field Block (Genitofemoral, Iliohypogastric and Ilioinguinal Nerve Block) for Inguinal Hernia Surgery
Analgesic Efficacy of Ultrasound-guided Inguinal Field Block (Genitofemoral, Iliohypogastric and Ilioinguinal Nerve Block) for Inguinal Hernia Surgery.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 87 (actual)
- Sponsor
- Azienda Ospedaliera San Gerardo di Monza · Academic / Other
- Sex
- Male
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the analgesic efficacy of an ultrasound-guided inguinal field block (block of the genitofemoral, iliohypogastric and ilioinguinal nerve).
Detailed description
Inguinal hernia repair accounts for 10-15% of all operations in general surgery. Moderate to severe pain can occur at the first day after inguinal hernia repair in 25% of patients at rest and in 60% during activity. On day 6 after the operation the incidence can be as high as 11% at rest and 33% during activity. Ultrasound imaging for regional anesthesia techniques have improved the success and safety rate of nerve blocks. We hypothesized that a procedure consisting of an ultrasound-guided inguinal field block (genitofemoral, iliohypogastric and ilioinguinal nerve block and incision line infiltration) could effectively control postoperative pain compared to selective unilateral subarachnoid anesthesia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Triple inguinal nerve block. | Ultrasound-guided genitofemoral, iliohypogastric and ilioinguinal nerve block with ropivacaine 5 mg/ml, 150 mg. |
| OTHER | Unilateral subarachnoid anesthesia | Subarachnoid anesthesia with hyperbaric bupivacaine 10 mg/ml, 12 mg, homolateral to inguinal hernia. |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2011-10-01
- Completion
- 2012-02-01
- First posted
- 2012-01-30
- Last updated
- 2014-02-04
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01521481. Inclusion in this directory is not an endorsement.